MedTrace Logo

Diagnostic Analysis of Oral Glucose Tolerance Test in Early Pregnancy for Gestational Diabetes Mellitus

NCT05487352 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 781

Last updated 2022-08-04

No results posted yet for this study

Summary

The aim of this study is to explore the diagnostic efficacy of oral glucose tolerance test in early pregnancy and establish the prediction model for gestational diabetes mellitus, so as to provide the optimal screening of gestational diabetes mellitus in the first trimester. The treatment started when the pregnancy was confirmed by transvaginal ultrasound (around 6 weeks of gestation) and continued until 42 days postpartum. The study is a single center, prospective cohort study. A total of 781 participants within 14 weeks of gestation were recruited.

Conditions

  • Gestational Diabetes Mellitus in Pregnancy

Interventions

OTHER

hyperglycemia exposure in the first trimester

The exposure means the hyperglycemia identified by the 75g oral glucose tolerance test before the 14 weeks of gestation

Sponsors & Collaborators

  • Women's Hospital School Of Medicine Zhejiang University

    lead OTHER

Principal Investigators

  • Dan Zhang, Dr · Women's Hospital School Of Medicine Zhejiang University

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-30
Primary Completion
2022-05-27
Completion
2022-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05487352 on ClinicalTrials.gov